These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10897771)

  • 1. [Surveillance of Barrett esophagus].
    Robaszkiewicz M
    Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B30-9. PubMed ID: 10897771
    [No Abstract]   [Full Text] [Related]  

  • 2. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ; Spechler SJ
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Topic Complex VI: Barrett esophagus].
    Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
    Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastroesophageal reflux disease and Barrett's esophagus.
    Anand O; Wani S; Sharma P
    Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K; Fujimori T; Ono Y; Masuyama H; Nakamura T; Terano A
    J Gastroenterol; 2002; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract]   [Full Text] [Related]  

  • 6. [Does symptomatic gastroesophageal reflux present a risk factor for development of adenocarcinoma of the esophagus?].
    Kellner H; Zoller WG
    Z Gastroenterol; 1999 Oct; 37(10):1071-3. PubMed ID: 10549101
    [No Abstract]   [Full Text] [Related]  

  • 7. [No grounds for Barrett hysteria. Current monitoring strategies are adequately reliable].
    Schilling D; Riemann JF
    MMW Fortschr Med; 2002 Jul; 144(27-28):40-1. PubMed ID: 12198878
    [No Abstract]   [Full Text] [Related]  

  • 8. [Markers of malignant potential and clinical management of dysplasia in Barrett esophagus].
    Roth JA; Hölscher AH; Schneider PM
    Chirurg; 1994 Feb; 65(2):96-101. PubMed ID: 8162821
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of heterozygosities in Barrett esophagus, dysplasia, and adenocarcinoma detected by esophageal brushing cytology and gastroesophageal biopsy.
    Lin X; Finkelstein SD; Zhu B; Ujevich BJ; Silverman JF
    Cancer; 2009 Feb; 117(1):57-66. PubMed ID: 19347831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Barrett metaplasia: how dangerous is it really?].
    Stolte M; Vieth M
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():5-8. PubMed ID: 12466995
    [No Abstract]   [Full Text] [Related]  

  • 11. Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.
    von Conrady D; Smith MJ; Khan MF; Tan S; Mortimer G; McAnena OJ
    Endoscopy; 2008 Sep; 40 Suppl 2():E68-9. PubMed ID: 18633915
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing dysplasia in Barrett's esophagus: are proton pump inhibitors the answer?
    Mardini HE
    Am J Gastroenterol; 2005 Apr; 100(4):978-9. PubMed ID: 15784046
    [No Abstract]   [Full Text] [Related]  

  • 14. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
    Tamayo de la Cuesta JL
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation and dilated columnar-lined esophagus.
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Oct; 104(10):2631; author reply 2632. PubMed ID: 19806096
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro.
    Wani S; Choi W; Sharma P
    Endoscopy; 2007 Jul; 39(7):643-6. PubMed ID: 17611920
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Contra.
    Vieth M
    Endoscopy; 2007 Jul; 39(7):647-9. PubMed ID: 17611921
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic factors for cancer in Barrett esophagus].
    Fléjou JF; Paraf F; Potet F; Fékété F
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D63-6. PubMed ID: 8013788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.